Drugs / Tetravac
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 3 | NCT00871000 Comparator | Apr → Nov 2009 | diphtheria, poliomyelitis, tetanus | GlaxoSmithKline | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Tetravac | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00871000 ↗ |
| Modality | Vaccine | “Tetravac™ vaccine” NCT00871000 ↗ |
| Route | Intramuscular | “Tetravac™ vaccine was administered intramuscularly” NCT00871000 ↗ |